BioMarin Pharma (BMRN) Reports Q4 Adj-EPS of 10c; Guides FY11 Sales
Tweet Send to a Friend
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) reported Q4 EPS of $0.10 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
